Guidelines currently limit time to initiate thrombolytic therapy in acute stroke to
4.5 hours after symptom onset. In contrast, endovascular thrombectomy has been shown
to improve outcomes in patients with salvageable brain tissue on imaging studies up
to 24 hours after the onset of symptoms. The use of tissue viability as the guide
to thrombectomy has also led to better outcomes compared to selection based on time
of onset. This study hypothesized that extending the time window for thrombolytic
therapy to 9 hours after onset of symptoms in patients with a small core of infarction
and a larger area of hypoperfusion would be beneficial.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Emergency MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
